135 related articles for article (PubMed ID: 29237546)
1. Impact of disease progression on health-related quality of life in patients with metastatic breast cancer in the PRAEGNANT breast cancer registry.
Müller V; Nabieva N; Häberle L; Taran FA; Hartkopf AD; Volz B; Overkamp F; Brandl AL; Kolberg HC; Hadji P; Tesch H; Ettl J; Lux MP; Lüftner D; Belleville E; Fasching PA; Janni W; Beckmann MW; Wimberger P; Hielscher C; Fehm TN; Brucker SY; Wallwiener D; Schneeweiss A; Wallwiener M
Breast; 2018 Feb; 37():154-160. PubMed ID: 29237546
[TBL] [Abstract][Full Text] [Related]
2. Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer.
Marschner N; Zacharias S; Lordick F; Hegewisch-Becker S; Martens U; Welt A; Hagen V; Gleiber W; Bohnet S; Kruggel L; Dille S; Nusch A; Dörfel S; Decker T; Jänicke M
JAMA Netw Open; 2020 Mar; 3(3):e200643. PubMed ID: 32154886
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life and its determinants in patients with metastatic renal cell carcinoma.
de Groot S; Redekop WK; Versteegh MM; Sleijfer S; Oosterwijk E; Kiemeney LALM; Uyl-de Groot CA
Qual Life Res; 2018 Jan; 27(1):115-124. PubMed ID: 28917029
[TBL] [Abstract][Full Text] [Related]
4. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
Bordeleau L; Szalai JP; Ennis M; Leszcz M; Speca M; Sela R; Doll R; Chochinov HM; Navarro M; Arnold A; Pritchard KI; Bezjak A; Llewellyn-Thomas HA; Sawka CA; Goodwin PJ
J Clin Oncol; 2003 May; 21(10):1944-51. PubMed ID: 12743147
[TBL] [Abstract][Full Text] [Related]
5. Observational Study to Assess Quality of Life in Patients with Pancreatic Neuroendocrine Tumors Receiving Treatment with Everolimus: The OBLIQUE Study (UK Phase IV Trial).
Ramage JK; Punia P; Faluyi O; Frilling A; Meyer T; Saharan R; Valle JW
Neuroendocrinology; 2019; 108(4):317-327. PubMed ID: 30699423
[TBL] [Abstract][Full Text] [Related]
6. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in elderly patients with newly diagnosed glioblastoma treated with short-course radiation therapy plus concomitant and adjuvant temozolomide.
Minniti G; Scaringi C; Baldoni A; Lanzetta G; De Sanctis V; Esposito V; Enrici RM
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):285-91. PubMed ID: 23642624
[TBL] [Abstract][Full Text] [Related]
8. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer.
Hurvitz SA; Lalla D; Crosby RD; Mathias SD
Breast Cancer Res Treat; 2013 Dec; 142(3):603-9. PubMed ID: 24218050
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072).
Coens C; van der Graaf WT; Blay JY; Chawla SP; Judson I; Sanfilippo R; Manson SC; Hodge RA; Marreaud S; Prins JB; Lugowska I; Litière S; Bottomley A
Cancer; 2015 Sep; 121(17):2933-41. PubMed ID: 26033286
[TBL] [Abstract][Full Text] [Related]
10. Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III AIO KRK 0207 trial.
Quidde J; Hegewisch-Becker S; Graeven U; Lerchenmüller CA; Killing B; Depenbusch R; Steffens CC; Lange T; Dietrich G; Stoehlmacher J; Reinacher A; Tannapfel A; Trarbach T; Marschner N; Schmoll HJ; Hinke A; Al-Batran SE; Arnold D
Ann Oncol; 2016 Dec; 27(12):2203-2210. PubMed ID: 27753609
[TBL] [Abstract][Full Text] [Related]
11. The effects of illness beliefs and chemotherapy impact on quality of life in Japanese and Dutch patients with breast or lung cancer.
van der Kloot WA; Uchida Y; Inoue K; Kobayashi K; Yamaoka K; Nortier HW; Kaptein AA
Chin Clin Oncol; 2016 Feb; 5(1):3. PubMed ID: 26932427
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial.
Bottomley A; Therasse P; Piccart M; Efficace F; Coens C; Gotay C; Welnicka-Jaskiewicz M; Mauriac L; Dyczka J; Cufer T; Lichinitser MR; Schornagel JH; Bonnefoi H; Shepherd L; ; ;
Lancet Oncol; 2005 May; 6(5):287-94. PubMed ID: 15863376
[TBL] [Abstract][Full Text] [Related]
13. Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry.
van der Poel MW; Oerlemans S; Schouten HC; van de Poll-Franse LV
Ann Hematol; 2015 Apr; 94(4):651-61. PubMed ID: 25471174
[TBL] [Abstract][Full Text] [Related]
14. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer.
Fatiregun OA; Olagunju AT; Erinfolami AR; Arogunmati OA; Fatiregun OA; Adeyemi JD
Breast; 2017 Feb; 31():150-156. PubMed ID: 27866090
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in patients with advanced renal cell carcinoma receiving pazopanib or placebo in a randomised phase III trial.
Cella D; Pickard AS; Duh MS; Guerin A; Mishagina N; Antràs L; Neary MP; McCann L; Hodge R; Sternberg CN
Eur J Cancer; 2012 Feb; 48(3):311-23. PubMed ID: 21689927
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of health-related quality of life in patients with breast cancer.
Ivanauskiene R; Kregzdyte R; Padaiga Z
Medicina (Kaunas); 2010; 46(5):351-9. PubMed ID: 20679752
[TBL] [Abstract][Full Text] [Related]
17. Quality of life of breast cancer patients in the course of adjuvant radiotherapy.
Budischewski K; Fischbeck S; Mose S
Support Care Cancer; 2008 Mar; 16(3):299-304. PubMed ID: 17680279
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing health related quality of life in cancer patients with bone metastases.
Wong E; Chow E; Zhang L; Bedard G; Lam K; Fairchild A; Vassiliou V; Alm El-Din MA; Jesus-Garcia R; Kumar A; Forges F; Tseng LM; Hou MF; Chie WC; Bottomley A
J Palliat Med; 2013 Aug; 16(8):915-21. PubMed ID: 23819731
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema.
Gjorup CA; Groenvold M; Hendel HW; Dahlstroem K; Drzewiecki KT; Klausen TW; Hölmich LR
Eur J Cancer; 2017 Nov; 85():122-132. PubMed ID: 28918186
[TBL] [Abstract][Full Text] [Related]
20. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
